Word

EHP

Status

Registered

Status Code

700

Status Date

Tuesday, February 2, 2021

Serial Number

79266404

Registration Number

6258611

Registration Date

Tuesday, February 2, 2021

Mark Type

4000

Filing Date

Wednesday, May 15, 2019

Published for Opposition

Tuesday, November 17, 2020

Trademark Owner History

Dr. med. Gerhard Siebenhüner - Original Registrant

Classifications

10 Medical apparatus for treating tumors of the human or animal body; apparatus for purifying the blood during surgical or therapeutic procedures; medical apparatus and instruments, namely, blood, blood purification, toxin, pesticide, parasite, drug, poison, heavy metal, bacteria and virus, immunopathogenic agent, bilirubin, and beta 2 microglobulin filters; medical apparatus and instruments, namely, drug delivery, blood, fluid, peristatic, membrane, and centrifugal pumps; medical apparatus and instruments, namely, adsorbers for blood purification and removal of toxins, pesticides, parasites, drugs, poison, heavy metal, bacteria, viruses, immunopathogenic agent, bilirubin, beta 2 microglobulin from the blood; medical apparatus and instruments, namely, heat exchangers, oxygenators, devices for ozone production, ozone devices for treatment of blood, ozone devices for the killing and removal of bacteria, viruses, and parasites, tube systems comprised of tubes for passing blood and fluids, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, blood perfusion devices, perfusion devices for the treatment of blood, perfusion cutlery for surgery; surgical apparatus and instruments; diagnostic and therapeutic equipment in the pharmaceutical, medical and veterinary fields, namely, equipment for blood gas analysis, devices for measuring blood coagulation, devices for measuring oxygen saturation, devices for measuring body temperature, hemoperfusion devices for the treatment of blood, clinical laboratory analyzers for blood and blood component analysis, chemistry analyzers for blood and blood component analysis, automated sample handling equipment for testing purposes, immunohematology analyzer for blood and blood component analysis, apparatus for blood screening, blood typing, detection of assays associated with blood screening and blood typing used in the transfusion medicine market; medical instruments for the extracorporeal destruction of cancer cells, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy; medical instruments for the extracorporeal purification of the blood and supply of natural or chemical substances to the body, namely, filter, pumps, adsorbers, infusion equipment for drug delivery, pain therapy, blood purification, blood perfusion; medical instruments, namely, patient cradle equipment suitable for use in hyperthermia, thermotherapy or thermometry treatments, namely, control devices, control systems, controller such as temperature controller; medical apparatus, equipment and instruments for chemotherapy and electrochemical tumor therapy; medical apparatus, namely, hyperthermia systems, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy

42 Advisory or additive services relating to therapy for the treatment of tumors of the human or animal body, namely development of medical imaging methods, laboratory analyses, chemosensitivity testing, gene analyses for medical research or diagnostic purposes; advisory or additive services relating to therapy for the purification of blood in surgical or theoretic procedures, namely imaging methods, laboratory analyses, medical laboratory chemosensitivity testing, gene analyses for medical research purposes, therapy monitoring for medical research purposes, therapy setting for medical research purposes, therapy adjustment for medical research purposes; services provided by a supplier of medical apparatus and instruments, namely technical advice relating to the operation of medical equipment and instruments adapted to the customer's specific applications, functional analysis, device adjustment in the nature of calibration, quality control, calibration of medical equipment and instruments; development and research services relating to new products for third parties in the field of hemoperfusion therapy or hyperthermia, therapy based on hyperthermia, oxygen supply and adsorption of molecules from blood; biological research; research in the field of chemistry; research in the field of hemoperfusion therapy or hyperthermia, therapy based on hyperthermia, oxygen supply and adsorption of molecules from blood

44 Medical services in the field of oncology; medical services for the treatment of diseases of the human or animal body; provision of heat therapy for treating tumors in human or animals, hyperthermia, hemoperfusion therapy; blood purification services for surgical or therapeutic procedures

Trademark Events

May 30, 2021

Final Decision Transaction Processed By Ib

May 6, 2021

Final Disposition Notice Sent To Ib

May 6, 2021

Final Disposition Processed

May 2, 2021

Final Disposition Notice Created, To Be Sent To Ib

Feb 2, 2021

Registered-Principal Register

Dec 12, 2020

Notification Processed By Ib

Nov 26, 2020

Notification Of Possible Opposition Sent To Ib

Nov 17, 2020

Official Gazette Publication Confirmation E-Mailed

Nov 17, 2020

Published For Opposition

Oct 28, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Oct 28, 2020

Notification Of Notice Of Publication E-Mailed

Oct 9, 2020

Approved For Pub - Principal Register

Oct 9, 2020

Examiner's Amendment Entered

Oct 9, 2020

Notification Of Examiners Amendment E-Mailed

Oct 9, 2020

Examiners Amendment E-Mailed

Oct 9, 2020

Examiners Amendment -Written

Aug 6, 2020

Notification For Req For Recon Denied No Appeal Filed

Aug 6, 2020

Action For Req For Recon Denied No Appeal Filed E-Mailed

Aug 6, 2020

Action Req For Recon Denied No Appeal Filed Counted Not Mailed

Jul 8, 2020

Teas/Email Correspondence Entered

Jul 7, 2020

Correspondence Received In Law Office

Jul 7, 2020

Teas Request For Reconsideration Received

Apr 14, 2020

Notification Of Final Refusal Emailed

Apr 14, 2020

Final Refusal E-Mailed

Apr 14, 2020

Final Refusal Written

Mar 20, 2020

Teas/Email Correspondence Entered

Mar 19, 2020

Correspondence Received In Law Office

Mar 19, 2020

Teas Response To Office Action Received

Oct 12, 2019

Refusal Processed By Ib

Sep 26, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Sep 26, 2019

Refusal Processed By Mpu

Sep 14, 2019

Application Filing Receipt Mailed

Sep 13, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Sep 12, 2019

Non-Final Action Written

Sep 10, 2019

Assigned To Examiner

Sep 10, 2019

New Application Office Supplied Data Entered In Tram

Aug 29, 2019

Sn Assigned For Sect 66a Appl From Ib